Antitumor and antimetastatic actions of anthrone-C-glucoside, cassialoin isolated from Cassia garrettiana heartwood in colon 26-bearing mice

Cancer Science

Volumn 99, Issue 11, 2008, Pages 2336-2348

  Kimura, Yoshiyuki ^a   Sumiyoshi, Maho ^a   Taniguchi, Masahiko ^b   Baba, Kimiye ^b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALOE EMODIN; CASSIA EXTRACT; CASSIA GARRETTIANA EXTRACT; CASSIALOIN; CD31 ANTIGEN; CHRYSOPHANIC ACID; CONCANAVALIN A; GAMMA INTERFERON; GELATINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CANCER INHIBITION; CASSIA GARRETTIANA; CD8+ T LYMPHOCYTE; CELL MIGRATION; CHEMICAL COMPOSITION; COLON CANCER; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG METABOLISM; IMMUNOMODULATION; MEDICINAL PLANT; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SOLVENT EXTRACTION; UMBILICAL VEIN; WOOD;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CASSIA; CELL LINE, TUMOR; CELLS, CULTURED; COLON; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; GLUCOSIDES; HUMANS; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; NEOPLASM METASTASIS;

EID: 55449108383     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00938.x     Document Type: Article

References (55)

1. Kimura Y, Baba K, Okuda H. Inhibitory effects of active substances isolated from Cassia garretiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (Part 1). Anticancer Res 2000; 20: 2899-906.
2. Kimura Y, Baba K, Okuda H. Inhibitory effects of active substances isolated from Cassia garretiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (Part 2). Anticancer Res 2000; 20: 2923-30.
3. Hata K, Baba K, Kozawa M. Chemical studies on the heartwood of Cassia garrettiana Craib. I. Anthraquinones including cassialoin, a new anthrone C-glycoside. Chem Pharm Bull 1978; 26: 3792-7.
4. Kimura Y, Okuda H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 2001; 131: 1844-9.
5. Kimura Y, Kido T, Takaku M, Sumoyoshi M, Baba K. Isolation of an anti-angiogenic substance from Agricus blazei Murill: Its antitumor and antimetastatic actions. Cancer Sci 2004; 95: 758-64.
6. Kimura Y, Sumiyoshi M. Antitumor and antimetastatic actions of eicosapentaenoic acid ethylester and its by-products formed during accelerated stability testing. Cancer Sci 2005; 96: 441-50.
7. Kimura Y, Baba K. Antitumor and antimetastatic activities of Angelica keiskei roots, Part 1: Isolation of an active substance, xanthoangelol. Int J Cancer 2003; 106: 429-37.
8. Albuquerque MLC, Waters CM, Slavia U, Schnaper HW, Flozak A. Shear stress enhances human endothelial cell wound closure in vitro. Am J Physiol Heart Circ Physiol 2000; 279: H293-302.
9. Chan TC, Chang CJ, Koonchanok NM, Gahlen RL. Selective inhibition of the growth of ras-transformed human bronchial epithelial cells by emodin, a protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun 1993; 193: 1152-8.
10. Zhang L, Chang C, Jm bacus SS, Hung MC. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res 1995; 55: 3890-6.
11. Kuo YC, Sun CM, Ou JC, Tsai WJ. A tumor cell growth inhibitor from Polygonum hypoleucum Ohwi. Life Sci 1997; 61: 2335-44.
12. Zhang L, Lau YK, Xia W, Hortobagyi GN, Hung MC. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clin Cancer Res 1999; 5: 343-53.
13. Pecere T, Gazzola MV, Mucignat C et al. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 2000; 60: 2800-4.
14. Lee HZ. Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma. Br J Pharmacol 2001; 134: 11-20.
15. Chen YC, Shen SC, Lee WR et al. Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem Pharmacol 2002; 64: 1713-24.
16. Srinivas G, Anto RJ, Srinivas P, Vidhyalakshmi S, Senan VP, Karunagaran D. Emodin induces apoptosis of human cervical cancer cells through poly (AD-ribose) polymerase cleavage and activation of caspase-9. Eur J Pharmacol 2003; 473: 117-25.
17. Cárdenas C, Quesada AR, Medina MA. Evaluation of the antiangiogenic of aloe-emodin. Cell Mol Life Sci 2006; 63: 3083-9.
18. Kaneshiro T, Morioka T, Inamine M et al. Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. Eur J Pharmacol 2006; 553: 46-53.
19. Kwak H-J, Park M-J, Park C-M et al. Emodin inhibits vascular endothelial growth factor-a-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Int J Cancer 2006; 118: 2711-20.
20. Esmat AY, Tomasetto C, Rio M-C. Cytotoxicity of a natural anthraquinone (aloin) against human breast cancer cell lines with and without ErbB-2-topoisomerase IIα complification. Cancer Biol Ther 2006; 5: 97-103.
21. Niæiforviæ A, Adziæ M, Spasiæ SD, Radojciæ MB. Antitumor effects of a natural antracycline analong (aloin) involve altered activity of antioxidant enzymes in HeLaS3 cells. Cancer Biol Ther 2007; 6: 1200-5.
22. Buenz EJ. Aloin induces apoptosis in Jurkat cells. Toxicol Vitro 2008; 22: 422-9.
23. 2 tension. Proc Natl Acad Sci 1995; 92: 5510-4.
24. Wagner RH, Gassmann M. Oxygen (es) and the hypoxia-inducible factor-1. J Biol Chem 1997; 378: 609-16.
25. Faquin WC, Schneider JJ, Goldberg MA. Effects of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-94.
26. Heillwig-Bügel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999; 94: 1561-7.
27. Thronton RC, Land D, Borghaei RC, Pease EA, Caro J, Mochan E. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synoviol fibrablasts. Biochem J 2000; 350: 307-12.
28. Folkman J, Klasgsbrum M. Angiogenic factors. Science 1987; 235: 442-7.
29. Klagsbrum M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991; 53: 217-39.
30. Folkman H, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-4.
31. Leung DW, Cachianes G, Kuang WJ, Goefel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9.
32. Bernatchez PN, Soker S, Sirois MG. Vascular endothelia growth effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J Biol Chem 1999; 274: 31047-54.
33. Davis-Smyth T, Chen H, Park J, Presta LG, Ferrara N. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor initate a signal transduction cascade. EMBO J 1996; 15: 4919-27.
34. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist 2000; 5: 3-10.
35. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptor. Nat Med 2003; 9: 669-76.
36. Meyer M, Clauss M, Lepple-Wienhues A et al. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 1999; 18: 363-74.
37. Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 2000; 19: 5598-605.
38. Kleiner DE, Steler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999; 43: S42-51.
39. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
40. Lotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
41. Macdougall JR, Matrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Meta Rev 1995; 14: 351-62.
42. Di GH, Lu JS, Song CG, Li HC, Shen ZZ, Shao ZM. Over expression of aromatase protein in highly related to MMPs levels in human breast carcinomas. J Exp Clin Cancer Res 2005; 24: 601-67.
43. Kim SH, Cho NH, Kim K et al. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) as vascular endothelial growth factor (VEGF) expression. J Surg Oncol 2006; 93: 330-7.
44. Zhao JX, Ynag LP, Wnag YF et al. Gelatinolytic activity of matrix metalloproteinase-2 and metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells. Eur J Neurol 2007; 14: 510-6.
45. Bergers G, Brekken R, McMahon G et al. Matrix metalloproteinase-9 triggers the angiogeneic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-44.
46. Kaliski A, Maggiorella L, Cengel KA et al. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Mol Cancer Ther 2005; 4: 1717-28.
47. Hattroi M, Kanda T, Shu YZ, Akao T, Kobayashi K, Namba T. Metabolism of barbaloin by intestinal bacteria. Chem Pharm Bull 1988; 36: 4462-6.
48. Che QM, Akao T, Hattori M, Kobayashi K, Namba T. Isolation of human intestinal bacterium capable of transforming barbaloin to aloe-emodin anthrone. Planta Med 1991; 57: 15-19.
49. + T cell in the antitumor immune response. J Exp Med 1998; 188: 2357-68.
50. + T cells. Cancer Sci 2005; 96: 695-705.
51. Marcovic SN, Murasko DM. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma. Cancer Res 1991; 51: 1124-8.
52. Turner JG, Rakhmilevich AL, Burdelya L et al. Anti-CD40 antibody induces antitumor and antimetastatic effects: The role of NK cells. J Immunol 2001; 166: 89-94.
53. Ikeda H, Old LJ, Schreiber RD. The roles of IFNγ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 2002; 13: 95-109.
54. + effector T cells reject tumors by direct antigen recognition but indirect action on host cells. J Immunol 2003; 170: 4427-31.
55. Irie T, Tsujii M, Tsuji S et al. Synergistic antitumor effects of celecoxib with 5-fluorouracil depend on IFN-γ. Int J Cancer 2007; 121: 878-83.